chrisvoncsefalvay/vaers-outcomes huggingface dataset:
flu like symptoms; arm soreness; fever; mixed with other vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN IN EXTREMITY (arm soreness), PYREXIA (fever) and INTERCHANGE OF VACCINE PRODUCTS (mixed with other vaccine) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer (Patient had 1st and 2nd dose by Pfizer). Concurrent medical conditions included HIV positive. Concomitant products included BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (BIKTARVY) for HIV infection.    On 23-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Sep-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN IN EXTREMITY (arm soreness), PYREXIA (fever) and INTERCHANGE OF VACCINE PRODUCTS (mixed with other vaccine). On 23-Sep-2021, INTERCHANGE OF VACCINE PRODUCTS (mixed with other vaccine) had resolved. On 25-Sep-2021, INFLUENZA LIKE ILLNESS (flu like symptoms) and PYREXIA (fever) had resolved. At the time of the report, PAIN IN EXTREMITY (arm soreness) had resolved.            Treatment information was not provided.
had 2nd shot of pfizer and thought I was going to die.  bad headache nausea, shortness of breath, body aches.  all of these were more severe than what the cdc said it would be.  could not go to the doctor since i was so weak.
Information has been received from a 70 year old female consumer with unspecified concomitant medications and no pertinent medical history or drug reactions or allergies reported, who "last week", on approximately 01-NOV-2009 was vaccinated with a dose of PNEUMOVAX 23 (route and lot # unknown) and experienced severe arm pain after receiving the vaccine. No specified lab diagnostics studies performed. It was unknown if the patient sought medical attention. The AE improved on therapy. The consumer stated that on 10-NOV-2009 she recovered. Follow up information has been received from the patient who stated that she received the PNEUMOVAX 23 on 05-NOV-2009 and no other shots were given at the time. The patient did have the seasonal flu shot two to three weeks prior to receiving PNEUMOVAX 23, on approximately 11-OCT-2009. The patient went back to the Doctor's office on 09-NOV-2009 and the Nurse there thought that they actually hit a nerve when they previously gave the patient the PNEUMOVAX 23. Immediately when the patient received the PNEUMOVAX 23 the patient experienced immediate tingling and pain from her shoulder to her wrist and the pain escalated as the day wore on and by bedtime the patient could hardly move her arm. The patient got up during the night she received PNEUMOVAX 23 and the pain was so horrific that she fell to the floor. The patient took ibuprofen and EXCEDRIN for the pain from the shot and later at bedtime a VICODIN for the pain. The patient stated that by the evening of the next day, on 06-NOV-2009, after receiving PNEUMOVAX 23 the pain was less severe but still extreme whenever the patient moved her arm. The patient said that the pain improved every day. As of the day before, on 12-NOV-2009 the patient still had some pain only when she used her arm in certain ways i.e. pulling up her pants was still painful. It was unknown if the patient sought medical attention. It was also reported that the patient recovered on 10-NOV-2009. Follow up information has been received from the physician concerning the 70 year old female patient with anxiety, osteoporosis, high cholesterol and no illness at the time of vaccination. On 15-OCT-2009 at 9:30 am the patient had been vaccinated with a IM dose of AFLURIA (Lot # 018492). On 05-NOV-2009 at 1:00 pm the patient was vaccinated with an IM dose of PNEUMOVAX 23 (Lot # 662842/1296X). It was reported that on 05-NOV-2009 the patient claimed tingling at her right arm after vaccine administration, which resolved completely within 5 days. On 11-NOV-2009 the patient recovered. No laboratory or diagnostic studies were performed. Additional information is expected.
Felt fatigue and lethargy within two hours of shot but 7 hours later, experienced severe abdominal  cramping which lasted at least four hours. After having bowel movement the following morning, again experienced sharp abdominal cramping pain which continues as I write this.
THE MORNING AFTER BEING VACCINATED I WOKE UP NAUSEOUS AS DAY PROGRESSED I STARTED FEELING TREMORS , A MIGRAINE , FEELING CLAMMY , COLD SWEAT AND AN UNWELL OVERALL FEELING, EXHAUSTED. ON 8/20/21 STILL FEELING EXHAUSTED AND CLAMMY AND SOME LIGHT HEADINESS
I started getting symptoms of a dry cough, tickle throat, and slight runny nose. Then today my symptoms have progressed to having chills also and a low grade fever 99.1. I have noticed that I don't have an appetite. I took a PCR test on 6/13/2022 and again on 6/14/2022, and 6/16/2022 which was negative. This morning I took a home COVID-19 test and it was positive and then a PCR test that is pending. I have contacted my doctor by email and I was prescribed PAXLOVID.
Post IM vaccine-day 2-upper body joint pain and low grade fever-(101.4) Day 3->Day 9-Extreme fatigue, temp to 103.4 evening-anorexia (wt loss of 9 lbs over 9 days) normal wt. 146 lbs. Dehydration. Heavy night sweats/for 12 days. Slow recovery 3 wks.
Person experienced nausea, aching joints, shaking chills, and headache. Reaction resolved Thursday (10/13) at noontime.
3/29-nausea and vomiting 1 hr after recieving vaccine; no other side effects reported
I got the injection on left deltoid and went to sit doe town. seafood allergy started to get hot, flush nasal passage way got really dry and got headache, face and mouth tingling. The headache felt like a rubber band around my head and continued to get hot 20 mins. When I got up to walk out felt light headed. Then went to the clinic dint feel right couldn't focus, temp was 100.Also exp gi problems had loose stool. I took Tylenol and Motrin for headache/fever and also on 12/17. Had to leave work early on 12/16 and was able to return on 12/17.
Information has been received from a physician concerning a female patient who in 1998 was vaccinated with a dose of hepatitis B virus vaccine rHBsAG (yeast). Six to eight months after vaccination she developed neutropenia and from the administration date " to the present" she has experienced pneumonia, pharyngitis and monarticular arthritis. Unspecified medical attention was sought. No product quality complaint was involved. Follow up information from the physician indicated that she did not patient and does not know who administered the vaccine, so she can not provide any additional information. Additional information is not expected.
Rec'd message from mother-pt admitted to hospital with neuro changes 5/16/07-12:51pm.  6/5/07 Received records from PCP which reveal patient on day of vax for well chld vs.  No problems noted.  Vax records received which confirm lot # & dose as reported. 6/22/07 Received hospital med recs which reveal patient experienced acute mental status changes, sudden onset left frontal HA, fatigue, sleepiness, urinary incontinence, difficult to arouse, loss of speech, unable to follow commands, right sided weakness, emesis.  Taken to ER where CT of head was WNL & labs were all WNL.  Started on IV antibiotics & antivirals in ER & transferred to higher level of care.  Admitted 5/15-6/7/07.  Was minimally responsive on arrival to hospital w/right side weakness, pupils minimally reactive, no speech, hyperreflexia of LEs.  Progressed to inpatient rehab service & continued to improve.  Developed RLL foot drop.  D/C to home on continued daily ASA & continued outpatient rehab services FINAL DX: right sided hemiplegia; stroke; impaired functional mobility; aphasia.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided.  On or about 01-JUN-2016, the patient was inoculated with the ZOSTAVAX vaccine as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 15-JUN-2016, the patient was treated at a medical facility for the onset of a vesicular rash, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 10-JUN-2013, the patient was vaccinated with ZOSTAVAX (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster, also known as shingles and other complications. On or about 30-JUL-2015, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as severe herpes zoster or shingles. The patient has been prescribed acyclovir for management of her painful symptoms and chronic pain. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
12/5/2020 about 15 -17 hours after Vaccine, Patient experienced fatigue, malaise. Temp was 99 and administered Tylenol at home. Temp at time of vaccine was 97.7. Patient felt better the following day after rest and sleep; 13 hours. Does have soreness at injection site.   Patient did not experience AE to first shingrix shot.   9/3/2020 - flu vaccine 9/9/2020 - 1st Shingrix shot
Bells palsy  sill have it    so far75 days dizziness while standing   approx 1 month
covid: tested positive; covid: tested positive; dose 5 (booster) Moderna Bivalent; This is a spontaneous report received from a contactable reporter (consumer). The reporter is the patient. A 55-year-old female patient (not pregnant) received BNT162b2 (PFIZER BIONTECH COVID-19 VACCINE), on 22Feb2021 as dose 1, single (lot number EN6200), on 15Mar2021 as dose 2, single (lot number EN6208), on 04Oct2021 as dose 3 (booster), single (lot number FF2589) and on 06Apr2022 as dose 4 (booster), single (lot number FF9893) at the age of 55 years for covid-19 immunisation; covid-19 vaccine nrvv MVa (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), on 20Sep2022 as dose 5 (booster), single (lot number AS7163B), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medication(s) were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 20Sep2022, outcome "unknown", described as "dose 5 (booster) Moderna Bivalent"; VACCINATION FAILURE (medically significant) and COVID-19 (medically significant) both with onset 16Dec2022, outcome "not recovered" and described as "covid: tested positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (16Dec2022) positive. Therapeutic measures were taken as a result of vaccination failure and covid-19. Clinical course: Tested positive on 16Dec2022 and started Paxlovid.
Rash erythematous. A nsg reported that an infant received her 1st injection of Prevnar in 3/01.  Approximately 4 days post vaccination the infant developed an overall body rash described as little red bumps all over the body.
High blood pressure; chest pain; back pain; numbness in limbs; nausea and vomiting.; inability to walk or move legs and feet.  Was officially diagnosed on 2/5/2021 wit Acute Sensory Axonal Neuropathy a severe/rare case of Guillain-Barre Syndrome.   Unknown time for recovery.  Is in the process of being referred to a rehab center.
When vaccine was given, patient noted muscle twinge/contraction in left arm and as the day progressed the upper arm started getting more sore radiating up into posterior shoulder and intermittent numbness/tingling into left 5th finger. Now having difficulty with abduction of left shoulder--pain and weakness.
severe fatigue; chills/rigors; fever; myalgia; global weakness; sweating; nausea; This is a spontaneous report from a contactable physician reported for herself. A 39-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Jan2021 06:45 at single dose (vaccine location=right arm) for covid-19 immunisation.  The patient medical history was not reported. No known allergies. Concomitant medication included escitalopram oxalate (LEXAPRO).  The patient previously received first dose of BNT162B2 on unspecified date at single dose for covid-19 immunisation. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not pregnant at the time of vaccination. The patient experienced severe fatigue, chills, fever, rigors, myalgia, global weakness, sweating and nausea on 21Jan2021 07:00 PM. It was unknown if treatment received for events. Patient did not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. The outcome of events was not recovered.    Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a possible contributory role of the suspect drug to the reported events  cannot be completely excluded based on temporal association. This case will be re-assessed when additional information becomes available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identifies as part of this review, as well as any appropriate action in response, will be promptly notifies to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
2nd dose administered on day 16.  Came in with children who were getting first doses.  It was not realized her second dose was too soon until after vaccine was administered.  Will review records more thoroughly.
From initial info received on 6/3/05 from a health care professional regarding an adverse event occurring in the USA, it was reported that an 18 year old female pt received her 1st dose of Menactra vaccine on 6/1/05. The product was administered SC in error, in the back of the pt's left arm. The next day, on 6/2/05, the pt developed a local reaction of redness, swelling and soreness at the site of injection. She was evaluated by a physician on 6/3/05. The pt was treated with ibuprofen and it is unknown whether she recovered from the events.
Pt was vaccinated with first varicella virus vaccine on 7/8/98. She received her second vaccination on 8/4/98. There were no concomitant meds. The pt had these vax in anticipation of becoming pregnant within the following year. The pt found out that she was pregnant in 1/00. On 2/9/00, pt had a blood test to see if she was immune to the varicella virus. The "Zoster Virus IGG" showed that she had no immunity to the varicella zoster virus. According to her rpt, in order to be immune a pt's score should be no less than 0.9. Her score was 0.12. The pt sought unspecified medical attention. No further details were provided. There were no adverse events noted. No further info is expected.
Had "asthma-like" attack, body aches, chills, "violent coughing", says lungs felt like they were on fire.
I am diabetic typo 2. Ever since I was given the Moderna vaccine for Covid-19, every time my blood glucose lowers, I don't have the same symptoms like I used to. It's a great danger because I can have seizures or organs failure that can lead to death if I'm not able to feel it and consequently provide a solution (sugar).
COMPLAINED OF FEELING LIGHTHEADED. PATIENT WAS PALE. LARGE EMESIS.  OBSERVED. REPORTED FEELING BETTER
Arm was sore; Arm was really sore; Right armpit underneath is little puffy; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), PAIN (Arm was really sore) and AXILLARY PAIN (Right armpit underneath is little puffy) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 030A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm was sore), PAIN (Arm was really sore) and AXILLARY PAIN (Right armpit underneath is little puffy). At the time of the report, PAIN IN EXTREMITY (Arm was sore), PAIN (Arm was really sore) and AXILLARY PAIN (Right armpit underneath is little puffy) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications not  provided Treatment information not provided
she had a situation in her arm: it had swelling; she has a hard time trying to raise it to her shoulder/also got pain in the forearm; Muscle pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 65 year-old female patient received bnt162b2 (BNT162B2), administration date 16Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "arthritis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "she had a situation in her arm: it had swelling"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "she has a hard time trying to raise it to her shoulder/also got pain in the forearm"; MYALGIA (non-serious), outcome "unknown", described as "Muscle pain".  Additional information: Reporter mentioned that his mother got the first dose of the Pfizer covid vaccine 2 weeks ago on March 16th and after that 2 week period she had a situation in her arm: it had swelling and she has a hard time trying to raise it to her shoulder and also got pain in the forearm. He said that there is notorious difference between each arm. He calls to report the situation and to know what they can do about it. Patient has arthritis and was born in the year 1956. Response included and explained the reporter that there were reports of pain and swelling in the injection site as well as muscle pain, so this could be most likely a side effect to the covid vaccine. Recommended consulting a physician for medical recommendations and guidance on the situation.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pain, swelling, redness at the site. Pt felt fatigued, and weak.
PATIENT WAS HAVING "STROKE LIKE SYMPTOMS" AND WENT TO LOCAL HOSPITAL EMERGENCY DEPARTMENT. THEY DID MULTIPLE TESTS AND DETERMINED THAT THE SYMPTOMS WERE A REACTION TO THE VACCINE. THIS WAS REPORTED TO ME BY THE PATIENT'S HUSBAND.
09/13/2006 pt received vaccinations, Rotavirus, Prevnar, Dtap, IPV, Comvax. beginning that evening pt having frequent stools diarrhea. Beginning on 9/17/06 mom noticed flecks of blood in diarrhea stool x 2 episodes, pt continues with diarrhea. OV pending for 9/19/06. Pt febrile, normal activity normal appetite Diet similac advance.
First symptom was left arm soreness around injection site and inability to sleep on left side. Upon waking patient noticed erythema, swelling, and bruising spanning approximately two inches in diameter from injection site.
Local reaction to immunization, no fever. (L) arm with erythema meaning 10x10cm, central induration off aprox 4x4cm. Mother instructed coll compresses.
My dad had received the Johnson and Johnson shot end of April. He was sick for a few days with the normal  side effects. In July he died from myocarditis the autopsy came back as.  Research has been showing that it is linked to the vaccine and to report it to help research just in case.
stronger reaction than after the first one; headache; Achy; felt a little bit like fluish; felt really bad; 1st dose on 06May2021 and 2nd dose on 17Jun2021; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (felt a little bit like fluish), FEELING ABNORMAL (felt really bad ), VACCINATION COMPLICATION (stronger reaction than after the first one), HEADACHE (headache) and MYALGIA (Achy) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 054L21A and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Jun-2021, the patient experienced FEELING ABNORMAL (felt really bad ) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 06May2021 and 2nd dose on 17Jun2021). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (felt a little bit like fluish), VACCINATION COMPLICATION (stronger reaction than after the first one), HEADACHE (headache) and MYALGIA (Achy). On 17-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 06May2021 and 2nd dose on 17Jun2021) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (felt a little bit like fluish), FEELING ABNORMAL (felt really bad ), VACCINATION COMPLICATION (stronger reaction than after the first one), HEADACHE (headache) and MYALGIA (Achy) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment information was not reported.  Patient had felt really bad the first night, they were achy and had headache and a stronger reaction than after the first one, but lasted less than 2 days.   This case was linked to MOD-2021-339360 (Patient Link).